IPOs - Page 2 | TalkMarkets

Content

All Posts > Content under IPOs
17 to 32 of 1837 Posts
<<< 1 2 3 4 ... 115 >>>
Reddit To IPO At The Top End Of Price Range
Article By: Fiona Cincotta
Thursday, March 21, 2024 6:15 AM EDT
Reddit will start trading today on the NYSE and has been priced at $34, the top end of its price guidance range.
In this article: RDDT
Read
Reddit’s Upcoming IPO: Upsides And Downsides
Article By: The Tokenist
Monday, March 18, 2024 2:36 PM EDT
With stagnant ARPU, can Reddit become a profitable company?
Read
Ride-Hailing Startup Ryde Makes Public Debut
Article By: The Fly
Sunday, March 10, 2024 12:20 PM EDT
Shares of the Singapore-based ride-hailing startup Ryde Group rose in their trading debut this week after pricing the IPO at the low end of expectations. Meanwhile, Lucas GC opened on March 5 at $5.
In this article: RYDE, LGCL, SMXT, CHRO, UMAC
Read
Reddit Finally Files For IPO, But Its Users Aren’t Thrilled
Article By: The Tokenist
Friday, February 23, 2024 12:07 PM EDT
Reddit's planned IPO was met with overwhelming negativity from its users, who fear increased moderation and monetization will undermine the community-driven ethos.
In this article: GOOG, META
Read
5 Signs Of An IPO Resurgence
Article By: Zacks Investment Research
Sunday, February 11, 2024 4:20 PM EDT
For investors, a thriving IPO market opens up the door to fresh investment opportunities and allows the public to participate in the most innovative and fastest-growing companies. Here are 5 signs that IPOs will make a resurgence in 2024.
In this article: SPCE, NXT, CAVA, ARM
Read
Gilead-Backed Kyverna Overshoots Raised IPO Expectations
Article By: The Fly
Sunday, February 11, 2024 2:20 PM EDT
Kyverna Therapeutics raised almost $320 million in its initial public offering, which was priced above the marketed range. Backed by Gilead Sciences, the company's offering was the second largest for a drug developer this year.
In this article: KYTX, MGX, TBBB, TELO, PMNT, AHR Also: GILD, HLXB, LEGT
Read
The Worst-Performing U.S. IPOs Of 2023
Article By: Jeff Desjardins
Sunday, February 4, 2024 4:00 PM EDT
In 2023, there were 154 IPOs on the U.S. stock market. Here is a brief look at some of the worst-performing initial public offerings from last year.
In this article: LSDI, MGRX, SRFM, HRYU, UCAR Also: ZJYL
Read
The Best-Performing U.S. IPOs Of 2023
Article By: Jeff Desjardins
Sunday, February 4, 2024 2:20 PM EDT
In 2023, there were 154 IPOs on the U.S. stock market. Here is a look at some of the best initial public offerings from last year.
In this article: GPCR, RYZB, ZJYL Also: UCAR
Read
Maker Of Wilson Tennis Rackets Raises $1.37 Billion In Discounted IPO
Article By: The Fly
Sunday, February 4, 2024 1:00 PM EDT
Amer Sports, the maker of Wilson tennis rackets and a host of other sports equipment, raised about $1.37 billion in its initial public offering, which was priced below the previously expected $16-$18 range. This was yet another disappointing IPO.
In this article: ROMA, AS, ANRO, GUTS, AMIX, SDHC, SYNX
Read
Forget AI Bubble. A New One Emerges As Space Firms Prepare For IPO Launchpad
Article By: Tyler Durden
Saturday, February 3, 2024 2:20 PM EDT
The world's first commercial spaceplane entered the final testing phase ahead of its first flight in 2024 in December. Now, the company behind the orbital-class spaceplane, Sierra Space Corp., is laying the groundwork for an initial public offering.
Read
Basketball-Maker Will Bounce Back From IPO Brick
Article By: Lipper Alpha Insight
Saturday, February 3, 2024 1:00 PM EDT
If any company knows how to rebound from an ugly brick shot, it should be one in the basketball business. Amer Sports badly missed on the pricing of its initial public offering, despite having an all-star roster of underwriters.
In this article: AS Also: DKS, NKE, ANPDY, LULU, ONON, BTSG
Read
KKR-Backed BrightSpring Prices Below Expectations, Then Opens Lower
Article By: The Fly
Sunday, January 28, 2024 12:20 PM EDT
Health-care services provider BrightSpring, which is backed by private equity firm KKR, priced its initial public offering at $13, below a marketed range of $15 to $18 per share, before opening on Friday a dollar below that IPO price.
In this article: KKR, HAO, AVBP, BTSG, NCDL, CGON, MSDL, JL, SUGP
Read
Week In Review: Arrivent BioPharma Raises $175 Million In IPO For In-Licensings From China
Article By: ChinaBio® Today
Saturday, January 27, 2024 1:40 PM EDT
ArriVent BioPharma priced its upsized Nasdaq IPO at $18 dollars per share, raising $175 million. The company’s stated goal is to find promising novel assets from China and other countries, which it aims to bring to the US market.
In this article: BNTX, SGMT, AVBP Also: ASCLF
Read
Insiders Are Bailing Out…
Article By: Macro-Ops
Monday, January 8, 2024 8:11 AM EDT
In this week’s Dirty Dozen we talk about speculators buying the dip in Qs along with that means for this selloff. We then discuss the very high insider sell ratio, look at active fund positioning, walk through Japan fundamentals.
In this article: KGS Also: GLD, SPX, SPTL
Read
Shenzhen's 2024 First IPO: RoboSense Debuts In Hong Kong, Valued Near HKD 20 Billion
Article By: EqualOcean
Saturday, January 6, 2024 2:41 PM EDT
At the issue price, RoboSense's IPO valuation exceeds HKD 19.3 billion, making it the world's highest-valued laser radar company.
In this article: BABA, THNQ
Read
Ten IPOs To Watch In 2024
Article By: The Fly
Sunday, December 31, 2023 10:40 AM EDT
After hitting a peak in 2021, the global IPO market had one of its worst years in 2022. This year wasn't much different, as IPO volumes saw a further decline of about 5%. Many, however, are expecting a recovery in the IPO markets in 2024.
In this article: ADBE, MSFT, NVDA, SNOW
Read
17 to 32 of 1837 Posts
<<< 1 2 3 4 ... 115 >>>